| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ENTELLUS MEDICAL INC | 3,489,533 | 62,881,000 | 35.17% | ||
| 2 | OPHTHOTECH CORP COM | 1,103,981 | 44,734,000 | 25.02% | ||
| 3 | OCULAR THERAPEUTIX INC | 1,932,607 | 27,172,000 | 15.20% | ||
| 4 | Catabasis Pharmaceuticals Inc | 2,857,667 | 23,118,000 | 12.93% | ||
| 5 | TRANSENTERIX INC | 7,546,692 | 17,056,000 | 9.54% | ||
| 6 | LOMBARD MEDICAL INC | 1,077,499 | 3,847,000 | 2.15% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-15-012108, filed 2015.11.16).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
